FDA Inspection 1170087 — OU Health Reproductive Medicine Lab

OU Health Reproductive Medicine Lab — FEI 3004961294

The FDA completed an inspection of OU Health Reproductive Medicine Lab on April 18, 2022 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 18, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Oklahoma City, OK (United States)